Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for High-Risk Adipocytic Retroperitoneal Sarcomas

NCT06025747 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT06025747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06025747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for High-Risk Adipocytic Retroperitoneal Sarcomas
Lead sponsor
University of Washington
Phase
Phase 1
Overall status
Recruiting
Start date
March 19, 2025
Completion date
March 3, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dedifferentiated liposarcoma, liposarcoma, retroperitoneal sarcoma